{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+MDI&page=2", "query": { "intervention": "Fluticasone MDI", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 39, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+MDI&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+MDI&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T17:20:07.079Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00307970", "title": "Impact of Anti-static Chamber/Mask", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "HFA FP MDI", "type": "DRUG" }, { "name": "conventional chamber/mask; anti-static chamber/mask", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "6 Years", "sex": "ALL", "summary": "1 Year to 6 Years" }, "enrollment_count": 12, "start_date": "2003-04", "completion_date": "2003-09", "has_results": false, "last_update_posted_date": "2011-09-20", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00307970" }, { "nct_id": "NCT03474081", "title": "A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA inhaler", "type": "DEVICE" }, { "name": "HANDIHALER", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 800, "start_date": "2018-03-29", "completion_date": "2019-07-17", "has_results": true, "last_update_posted_date": "2021-07-15", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 33, "location_summary": "Andalusia, Alabama • Huntington Beach, California • Sacramento, California + 29 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Simi Valley", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03474081" }, { "nct_id": "NCT02141854", "title": "Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FS MDPI", "type": "DRUG" }, { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol/salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 882, "start_date": "2014-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 85, "location_summary": "Birmingham, Alabama • Little Rock, Alaska • Phoenix, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02141854" }, { "nct_id": "NCT01103349", "title": "BI 671800 in Asthmatic Patients on Inhaled Corticosteroids", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BI 671800", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 243, "start_date": "2010-04-20", "completion_date": "2011-08-09", "has_results": true, "last_update_posted_date": "2022-05-31", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 6, "location_summary": "Denver, Colorado • North Dartmouth, Massachusetts • Plymouth, Minnesota + 3 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Plymouth", "state": "Minnesota" }, { "city": "Portland", "state": "Oregon" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01103349" }, { "nct_id": "NCT01092143", "title": "BI 671800 ED in Steroid-naive Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BI 671800", "type": "DRUG" }, { "name": "Fluticasone propionate placebo", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "BI 671800 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 389, "start_date": "2010-03-18", "completion_date": "2011-03-26", "has_results": true, "last_update_posted_date": "2022-05-31", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 40, "location_summary": "Tucson, Arizona • Cypress, California • Los Angeles, California + 34 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Cypress", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01092143" }, { "nct_id": "NCT00576069", "title": "Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "fluticasone/salmeterol", "type": "DRUG" }, { "name": "mometasone/formoterol", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "10 Years to 95 Years" }, "enrollment_count": 60, "start_date": "2007-10-25", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00576069" }, { "nct_id": "NCT00633217", "title": "Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol DISKUS 250/50mcg", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 247, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 16, "location_summary": "Jasper, Alabama • Mobile, Alabama • Lafayette, Louisiana + 13 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Sunset", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633217" }, { "nct_id": "NCT01216735", "title": "Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tobacco Abuse Smoke" ], "interventions": [ { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "30 Years to 65 Years" }, "enrollment_count": 32, "start_date": "2008-09", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2016-06-29", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01216735" }, { "nct_id": "NCT02175771", "title": "Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "FLOVENT HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "albuterol/salbutamol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 758, "start_date": "2014-07", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Pell City, Alabama + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02175771" }, { "nct_id": "NCT00214019", "title": "The Effect of Salmeterol on Eosinophil (EOS) Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Allergic Asthma" ], "interventions": [ { "name": "salmeterol", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 36, "start_date": "2003-11", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2017-11-21", "last_synced_at": "2026-10-01T17:20:07.079Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00214019" } ] }